In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

Enthera Pharmaceuticals ("Enthera"), a clinical-stage biotech company developing a first-in-class antibody therapeutic targeting the Insulin Growth Factor Binding Protein 3 (IGFBP3)/TMEM219 pathway ...

One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.

RFK Jr. removes Covid-19 vaccines from CDC recommendations for healthy children and pregnant women without scientific ...

Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of ...

ATLANTA and BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- ABLi Therapeutics ("ABLi”), a biotechnology company developing ...

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting ...